What happens if you're allergic to semaglutide?

Can you actually be allergic to Wegovy or semaglutide?

Yes, though it is uncommon. The NHS medicines page for semaglutide lists serious allergic reaction as a known but rare possibility. Like any medicine, semaglutide can trigger an immune response in certain individuals, and the reaction may involve the active molecule itself or an excipient, one of the inactive ingredients that make up the injection.

The confusion arises because semaglutide's most frequent side effects are gastrointestinal: nausea, loose stools, indigestion, and occasional vomiting. These affect a significant proportion of people in the first few weeks of treatment and are not allergic in nature. They are the body adjusting to a medicine that slows gastric emptying and changes appetite signalling. Redness or mild discomfort at the injection site is similarly common and usually settles within a day or two. Neither of these patterns means you are allergic to Wegovy.

Allergic symptoms look different. The ones that require urgent attention are hives or a spreading rash, swelling around the face, lips or throat, a tight chest, or difficulty breathing. If any of those develop after an injection, call 999 or go to A&E. Do not administer the next dose before speaking to a clinician. You can also read more about the specific symptoms that suggest a Wegovy allergy to understand which signs to watch for.

What should you do if you think you're having a reaction?

This is a question our prescribers hear most weeks, and the answer is more straightforward than people expect. If the reaction is severe (throat swelling, breathing difficulty, a fast heartbeat alongside a rash) treat it as a medical emergency. An anaphylactic reaction needs adrenaline and hospital assessment, not a phone call to a pharmacy.

For milder but persistent or unusual symptoms, the practical steps are: stop the current pen, note exactly what happened and when (the date, which dose, how long after injection), and contact a doctor or call 111. Do not restart until a clinician has reviewed what occurred. If you are already a patient with an online pharmacy, contact their aftercare team promptly. At nume, our support line is open seven days a week for exactly this kind of concern.

Reporting a suspected reaction formally matters too. The MHRA's Yellow Card scheme lets patients and healthcare professionals flag side effects, including allergic ones, and this data informs ongoing safety monitoring. You can submit a report at yellowcard.mhra.gov.uk. It takes a few minutes and genuinely contributes to post-market surveillance for newer medicines.

You might also find it useful to look at the broader picture of semaglutide side effects to distinguish between expected early effects and anything that warrants escalation.

If you are allergic to semaglutide, are there alternatives for weight management?

Possibly, yes. The key is that semaglutide and tirzepatide (the active ingredient in Mounjaro) work on overlapping but not identical pathways. Tirzepatide is a dual GIP and GLP-1 receptor agonist, structurally distinct from semaglutide, which acts on the GLP-1 receptor only. A person who has experienced an allergic reaction to semaglutide has not necessarily reacted to the GLP-1 pathway itself, the reaction may have been to a part of the semaglutide molecule or its formulation. Whether tirzepatide is suitable after a semaglutide reaction is a clinical decision, not a general rule.

A prescriber will want to know the nature and severity of the reaction before recommending anything. Mild injection-site sensitivity is treated differently from systemic allergy. A history of anaphylaxis to any GLP-1 medicine would prompt much more caution. This is precisely why a detailed clinical assessment (not a symptom checker) is the appropriate next step.

If you are exploring your options after a reaction, our free consultation page outlines how nume's clinical review works. There is no cost to the assessment, and a GPhC-registered Independent Prescriber reviews every submission the same day. It is also worth reading about Wegovy's full side-effect profile if you are trying to understand the broader risk picture before making any decision.

For a deeper look at another serious but distinct risk associated with GLP-1 medicines, the evidence on pancreatitis and semaglutide is covered separately. And if cost is part of your thinking as you weigh up next steps, our guide to Wegovy pricing in the UK sets out what legitimate private treatment actually involves.